Depo-Medrol

Depo-Medrol is a brand name of methylprednisolone, approved by the FDA in the following formulation(s):

DEPO-MEDROL (methylprednisolone acetate - injectable; injection)

• 
  Manufacturer: PHARMACIA AND UPJOHN
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 20MG/ML ^[RLD], 40MG/ML ^[RLD][AB], 80MG/ML ^[RLD][AB]

Has a generic version of Depo-Medrol been approved?

Yes. The following products are equivalent to Depo-Medrol:

methylprednisolone acetate injectable; injection

• 
  Manufacturer: SANDOZ
  
  Approval date: January 29, 2009
  
  Strength(s): 40MG/ML ^[AB], 80MG/ML ^[AB]


• 
  Manufacturer: SANDOZ
  
  Approval date: March 5, 2009
  
  Strength(s): 40MG/ML ^[AB], 80MG/ML ^[AB]


• 
  Manufacturer: TEVA PARENTERAL
  
  Approval date: February 23, 2005
  
  Strength(s): 40MG/ML ^[AB], 80MG/ML ^[AB]


• 
  Manufacturer: TEVA PARENTERAL
  
  Approval date: October 27, 2006
  
  Strength(s): 40MG/ML ^[AB], 80MG/ML ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Depo-Medrol. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Depo-Medrol.

See also...

• Depo-Medrol Suspension Consumer Information (Wolters Kluwer)
• Methylprednisolone Consumer Information (Drugs.com)
• Methylprednisolone Consumer Information (Wolters Kluwer)
• Methylprednisolone Solution Consumer Information (Wolters Kluwer)
• Methylprednisolone Suspension Consumer Information (Wolters Kluwer)
• Methylprednisolone Consumer Information (Cerner Multum)
• Methylprednisolone AHFS DI Monographs (ASHP)
• Methylprednisolone Acetate AHFS DI Monographs (ASHP)
• Methylprednisolone Sodium Succinate AHFS DI Monographs (ASHP)